Founder RDM Enterprises. CEO N8 Medical, Cora Therapeutics Nellix Inc, Millimed Holdings, President Endologix, COO Angio Dynamics, SVP Cook Medical, EVP Align Technologies.
Current CEO of Aclipse Therapeutics, Former CEO & Co-Founder of Thar Pharmaceuticals, Automated Cell, and Suprex Corporation
Industry veteran led Becton Dickinson IV catheter business, EVP for Vizient, the worlds largest GPO.
Industry veteran, Former VP of R&D at CR Bard leading antimicrobial device coatings.
Highly accomplished medical researcher. Chief Scientific Officer and SVP for Hackensack Meridian Health Center for discover and innovation
Chief of the Interventional Cardiology Devices Branch in the Division of Cardiovascular Devices at the US Food and Drug Administration.
UCSF’s director and surgical chief of Cardiac Transplantation and Mechanical Circulatory Support.
N8 Medical, Inc. (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.The subsidiaries for N8 Medical Inc are N8 Medical, LLC for Medical Device Development and Kinnear Pharmaceuticals, LLC for drug development.
N8 Medical is proudly powered by WordPress